Laparoscopic/robotic simple prostatectomy

Rao S. Mandalapu, Adnan Ali, Sailaja Pisipati, Ashutosh K. Tewari

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Benign prostatic hyperplasia is the most common benign neoplasm in American men, affecting nearly 6.5 million men aged 50-79 years in the United States. The treatment options for clinically significant benign prostatic hyperplasia have dramatically changed in the recent past with the development of minimally invasive procedures and advanced medical therapies. However, open prostatectomy remains the surgery of choice in selected patients. Simple prostatectomy used to be the primary treatment of choice for symptomatic patients with benign prostatic hyperplasia (BPH). In an attempt to reduce the length of hospital stay and morbidity associated with open prostatectomy, minimally invasive approaches have evolved. Robot-assisted simple prostatectomy (RASP) holds potential for improving perioperative outcomes following simple prostatectomy. In this chapter we briefly describe the indications, contraindications, prevalent techniques, and complications of RASP.

Original languageEnglish
Title of host publicationTreatment of Benign Prostatic Hyperplasia
Subtitle of host publicationModern Alternative to Transurethral Resection of the Prostate
PublisherSpringer New York
Number of pages8
ISBN (Electronic)9781493915873
ISBN (Print)9781493915866
StatePublished - 1 Jan 2015


Dive into the research topics of 'Laparoscopic/robotic simple prostatectomy'. Together they form a unique fingerprint.

Cite this